Table 4.
Samples | Size (nm) | Ms (emu/g) | EEPG (%) |
PG Release over 1 h (%) | IC50 (μg/mL) | |||
---|---|---|---|---|---|---|---|---|
TEM | DLS | No-Enzyme | With-Enzyme | MCF-7/GFP Cell Line | HepG2 Cell Line | |||
Fe3O4/CMCS | 9.8 | 38.1 | 65.01 | 91.78 | 6.95 | 44.61 | 0.8544 | 1.05 |
Fe3O4/β-CD | 14.2 | 121.1 | 37.48 | 80.93 | 3.59 | 58.24 | 2.61 | 1.79 |
Carboxymethyl chitosan (CMCS), β-cyclodextrin (β-CD), Saturation magnetization (Ms), Encapsulation efficiency of prodigiosin (EEPG), The half-maximal inhibitory concentration (IC50).